Abstract:Objectives Postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery and affects around 30% of patients. Variable guidelines from multiple organizations exist for the prevention of POAF after cardiac surgery. A survey of UK practice was conducted to define “usual care” for a platform trial of interventions to prevent POAF after cardiac surgery. To provide context for the survey, all current guidelines for the prevention and management of atrial fibrillation (AF) after cardiac surgery were reviewed. Design Online survey and literature review. Setting All 35 UK National Health Service Cardiac Surgery Centres participated in the survey. Guidelines from specialist societies and other guideline-making organizations from the UK, Europe, and North America were reviewed. Participants Established a link network of researchers. Measurements and Main Results Five relevant guidelines were identified from the literature review. All guidelines recommend β-blockade for prevention of AF after cardiac surgery. Treatment of AF is recommended using either rate or rhythm control. Cardioversion is recommended only for the hemodynamically unstable patient. Patients who remain in AF for over 48 hours should be considered for anticoagulation. Patients should be followed up within 60 days to review the need for antiarrhythmic and anticoagulant therapy. Of 35 centers, 31 (89%) responded. A total of 11 of 31 (35.5%) centers followed local guidance for prevention of POAF, 4 (13%) centers followed Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthesia guidelines, 4 (13%) followed UK National Institute of Health and Care Excellence guidance and 4 followed “other” guidance. Of 31 centers, 8 (26%) followed no guidelines to prevent POAF; 28 of 31 (90%) centers did not risk-stratify their patients for POAF. Most centers (23/31, 74%) did not have a care package in place to prevent POAF, but 14 of 31 (45%) try in some way to prevent AF in patients presenting with sinus rhythm. The most common interventions to prevent POAF are β-blocker use postoperatively (23/31, 74%), magnesium (20/31, 64.5%), and maintaining a serum K+ ≥4.5 mmol/L (26/31, 84%). Conclusions Guidance to prevent AF after cardiac surgery centers around the use of β-blockade. Although patients in the UK do not appear to be risk-assessed for POAF, the main interventions used to prevent it are similar: β-blockade and maintenance of serum K+ and Mg2+ levels.

Anticoagulation management of post-cardiac surgery new-onset atrial fibrillation

Postoperative Atrial Fibrillation: A Review

Review of Anticoagulant Prescribing Patterns in New Onset Atrial Fibrillation After Cardiac Surgery

Role of anticoagulation therapy in modifying stroke risk associated with new-onset atrial fibrillation after non-cardiac surgery

Pharmacological management of atrial fibrillation following cardiac surgery

Prevention of atrial fibrillation in cardiac surgery: time to consider a multimodality pharmacological approach

A Systematic Review of Ongoing Registered Research Studies on Post-Operative Atrial Fibrillation after Cardiac Surgery

Post-Operative Atrial Fibrillation: Current Treatments and Etiologies for a Persistent Surgical Complication

New‐Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Risk of Adverse Events: An Analysis From the CORONARY Trial

New-onset atrial fibrillation and acute coronary syndrome

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients with Atrial Fibrillation

Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis

Optimal Timing and Duration of Beta-Blocker Therapy for Preventing Postoperative Atrial Fibrillation: A Literature Review

Prospective Study of Risk Factors for Postoperative Atrial Fibrillation After Cardiac Surgery

In-hospital Outcomes and Post Discharge Mortality in Patients with Acute Coronary Syndrome and Atrial Fibrillation

Risk factors of new-onset postoperative atrial fibrillation in critically ill patients after non-cardiac surgery

An update on guidelines to prevent and manage Atrial Fibrillation after cardiac surgery and a survey of practice in the UK.

To Anticoagulate or Not?

New-onset post-operative AF recurrence after cardiac surgery detected by implantable loop recorders: A systematic review and Meta-analysis

Cardiopulmonary bypass management and risk of new-onset atrial fibrillation after cardiac surgery

Abstract WP98: Variability of Perioperative Anticoagulation Strategies in Patients With Atrial Fibrillation